U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 3Cl.In.3H2O
Molecular Weight 275.223
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of INDIUM CHLORIDE TRIHYDRATE

SMILES

O.O.O.[Cl-].[Cl-].[Cl-].[In+3]

InChI

InChIKey=OTTYOCHOVATAEM-UHFFFAOYSA-K
InChI=1S/3ClH.In.3H2O/h3*1H;;3*1H2/q;;;+3;;;/p-3

HIDE SMILES / InChI
Indium is a rare, soft silvery-white metal. It is used in some manufacturing process, butt here is no known biological role for indium in the human body. Although there are claims that indium increases hormone production, stimulates immune system function, and increases energy, there is no reliable scientific evidence to support such claims. In vitro, indium-III salts appears to have cytotoxic activity against melanoma. Indium cation (Indium-III), when complexed with 8-hydroxyquinoline (oxine), has been employed as a radioactive platelet label for thrombus imaging in animals and man. The short half-life (2.8 d) and high yield of gamma photons of 111In make it ideal for in vitro counting and external imaging. Indium In 111 ProstaScint (Capromab Pendetide) is indicated as a diagnostic imaging agent in newly-diagnosed patients with biopsy-proven prostate cancer, thought to be clinically-localized after standard diagnostic evaluation (eg chest x-ray, bone scan, CT scan, or MRI), who are at high-risk for pelvic lymph node metastases. It is not indicated for patients who are not at high risk. Indium In 111 ProstaScint is also indicated as a diagnostic imaging agent in post-prostatectomy patients with a rising PSA and a negative or equivocal standard metastatic evaluation in whom there is a high clinical suspicion of occult metastatic disease.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P06214
Gene ID: 25374.0
Gene Symbol: Alad
Target Organism: Rattus norvegicus (Rat)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Indium In 111 Chloride

Approved Use

Indium In 111 Chloride Sterile Solution is indicated for radiolabeling OncoScint CR/OV or ProstaScint preparations used for in vivo diagnostic imaging procedures. It is also indicated for radiolabeling Zevalin preparations used for Radioimmunotherapy procedures. Please refer to the package insert for OncoScint CR/OV, ProstaScint or Zevalin for information on the final drug product. Indium In 111 ProstaScint (Capromab Pendetide) is indicated as a diagnostic imaging agent in newly-diagnosed patients with biopsy-proven prostate cancer, thought to be clinically-localized after standard diagnostic evaluation (eg chest x-ray, bone scan, CT scan, or MRI), who are at high-risk for pelvic lymph node metastases. It is not indicated for patients who are not at high risk. Indium In 111 ProstaScint is also indicated as a diagnostic imaging agent in post-prostatectomy patients with a rising PSA and a negative or equivocal standard metastatic evaluation in whom there is a high clinical suspicion of occult metastatic disease. The imaging performance of Indium In 111 ProstaScint following radiation therapy has not been studied.

Launch Date

1996
PubMed

PubMed

TitleDatePubMed
Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors.
2016-10-06
Effect of Metalation on Porphyrin-Based Bifunctional Agents in Tumor Imaging and Photodynamic Therapy.
2016-03-16
Preparation of indium-115-labeled diethylenetriaminetetraacetic acid monoacetamide peptides purified by 8-hydroxyquinoline.
2000-12-01
New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts.
1992-04
Patents

Sample Use Guides

Indium In 111 ProstaScint (Capromab Pendetide) has been administered in single doses to over 600 patients in clinical studies, and in repeat administrations (2 to 4 infusions) to 61 patients. A 0.5 mg dose was determined to be the lowest effective dose.
Route of Administration: Intravenous
One million alveolar macrophages obtained from hamsters were exposed to 60 ug of ferrosoferric oxide and 2, 4, 10 and 20 ug of Indium arsenide (InAs) particles.
Name Type Language
INDIUM, TRIAQUATRICHLORO-
Preferred Name English
INDIUM CHLORIDE TRIHYDRATE
Systematic Name English
TRIAQUATRICHLOROINDIUM
Common Name English
INDIUM CHLORIDE (INCL3), TRIHYDRATE
Systematic Name English
INDIUM TRICHLORIDE TRIHYDRATE
Systematic Name English
Code System Code Type Description
CAS
20471-73-2
Created by admin on Mon Mar 31 23:03:52 GMT 2025 , Edited by admin on Mon Mar 31 23:03:52 GMT 2025
PRIMARY
CAS
62057-69-6
Created by admin on Mon Mar 31 23:03:52 GMT 2025 , Edited by admin on Mon Mar 31 23:03:52 GMT 2025
ALTERNATIVE
PUBCHEM
14877292
Created by admin on Mon Mar 31 23:03:52 GMT 2025 , Edited by admin on Mon Mar 31 23:03:52 GMT 2025
PRIMARY
FDA UNII
LPS6485PXB
Created by admin on Mon Mar 31 23:03:52 GMT 2025 , Edited by admin on Mon Mar 31 23:03:52 GMT 2025
PRIMARY